Meet Our Team

The Sygnature leadership team embodies a dynamic and multifaceted fusion of diverse backgrounds, experiences, and expertise. With a shared dedication to excellence, this team unites passionate scientists, adept chemists, accomplished biochemists, seasoned biologists, proficient computational chemists, and skilled pharmacologists. Their collective synergy is the driving force behind Sygnature’s ascent as the unrivalled partner in the realm of drug discovery.

Armed with a profound understanding of the intricacies of the pharmaceutical landscape, the Sygnature team stands resolute in its commitment to being the pinnacle provider of drug discovery services. With an unwavering focus on achieving success, they employ a tireless work ethic and a wealth of knowledge to propel your project forward. Every facet of your journey is meticulously crafted and supported, demonstrating their dedication to not only meeting but exceeding your expectations.

At Sygnature Discovery, the pursuit of innovation and breakthroughs is more than a professional objective; it’s a shared passion that infuses their work with a unique vigour. Their diverse array of talents and perspectives ensures that every challenge is met with a spectrum of solutions, each one carefully tailored to the distinct demands of your project.

In essence, the Sygnature leadership team is not just a group of individuals; they are the embodiment of collective excellence. By entrusting your drug discovery project to their capable hands, you are choosing a partner that will navigate the complexities of the journey with you, propelling your aspirations to the forefront of scientific achievement. 

Filter by:

Dr Simon Hirst

Chief Executive Officer

VIEW BIO

Dr Paul Overton

Chief Commercial Officer

VIEW BIO

Dr Jonathan Williams

Chief Operating Officer

VIEW BIO

Dr David Witty

Chief Scientific Officer

VIEW BIO

Louisa Jordison

Chief Financial Officer

VIEW BIO

James Edgar

Chief People Officer

VIEW BIO

Dr Stuart Onions

Chief Technical Officer

VIEW BIO

Dr Allan Jordan

Vice President of Oncology Drug Discovery

VIEW BIO

Dr John Unitt

Vice President, Immunology and Inflammation Drug Discovery

VIEW BIO

Dr Max Mirza

Vice President, Neuroscience Drug Discovery

VIEW BIO

Dr Geraint Jones

Director of Chemistry

VIEW BIO

Colin Sambrook Smith

Director of Computational Sciences and Informatics

VIEW BIO

Jane Kendrew

Director of Translational Oncology

VIEW BIO

Dr Dave Pearson

Director of Form and Formulation

VIEW BIO

Dr Stephen Young

VP Business Development

VIEW BIO

Dr Emily Eaton

VP Commercial Services

VIEW BIO

Who We Are

Sygnature Discovery prides itself on offering a unique, high-quality, distinctive and tailored integrated drug discovery service to our clients. Our mission is to be admired for the science we do,…

DISCOVER

Working with Us

[embed]https://www.youtube.com/watch?v=hSEDjMTjWYg[/embed] No two projects will ever be the same, but there are commonly recurring challenges that hinder progress towards a strong candidate molecule. Sygnature draws on the past experience of…

DISCOVER

Company History

Since 2004 Sygnature Discovery has been offering high-quality drug discovery services and providing guidance and support to customers for the discovery and development of novel medicines. We have grown significantly…

DISCOVER